To delay or not to delay, that is the question for patients with acute lymphoblastic leukemia who do not receive prophylactic cranial irradiation

Cancer. 2018 Dec 1;124(23):4442-4446. doi: 10.1002/cncr.31756. Epub 2018 Oct 10.

Abstract

To determine the impact of delaying diagnostic lumbar puncture and initial intrathecal therapy on treatment outcome of children with newly diagnosed acute lymphoblastic leukemia (ALL) treated without prophylactic cranial irradiation, Yeh and colleagues updated their TPOG-ALL-2002 clinical trial. They found that this treatment strategy reduced the rate of traumatic lumbar puncture with blasts to zero, and tended to improve outcome of patients with a CNS-2 or CNS-3 status based on the event-free survival, the overall survival, and the cumulative risk of CNS relapse, as compared to historical controls.

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Decision-Making
  • Clinical Trials as Topic
  • Cranial Irradiation / adverse effects
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
  • Time-to-Treatment
  • Treatment Outcome

Substances

  • Antineoplastic Agents